Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
5076
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $518K | ﹤0.01% |
43,312
-11,626
| -21% | -$152K |
|
5077
Immunovant
IMVT
$8.64B
| $516K | ﹤0.01% |
92,431
-67,240
| -42% | -$329K |
|
5078
VolitionRx Ltd
VNRX
$6.47M
| $515K | ﹤0.01% |
18,918
-944
| -5% | -$35.7K |
|
5079
iShares MSCI Ireland ETF
EIRL
$78.8M
| $513K | ﹤0.01% |
13,848
-345
| -2% | -$14.3K |
|
|
TWAV
5080
TaoWeave Inc
TWAV
$4.92M
| $512K | ﹤0.01% |
5,694
| – | – |
|
5081
Franklin FTSE Brazil ETF
FLBR
$515M
| $511K | ﹤0.01% |
28,142
-1,515,174
| -98% | -$27.5M |
|
5082
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$884M
| $509K | ﹤0.01% |
24,829
-118,549
| -83% | -$2.58M |
|
5083
Telesat
TSAT
$771M
| $508K | ﹤0.01% |
65,022
-60,030
| -48% | -$663K |
|
5084
Evolus
EOLS
$538M
| $507K | ﹤0.01% |
63,000
-118,186
| -65% | -$1.25M |
|
5085
Custom Truck One Source
CTOS
$2.4B
| $506K | ﹤0.01% |
86,826
+9,058
| +12% | +$56.5K |
|
|
DXYN
5086
DELISTED
Dixie Group Inc
DXYN
| $506K | ﹤0.01% |
468,156
-17,995
| -4% | -$24K |
|
5087
Claros Mortgage Trust
CMTG
$257M
| $505K | ﹤0.01% |
42,999
+25,377
| +144% | +$435K |
|
|
PRTK
5088
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $505K | ﹤0.01% |
196,690
-12,554
| -6% | -$31.2K |
|
|
MESO
5089
Mesoblast
MESO
$2.02B
| $501K | ﹤0.01% |
98,614
+28,216
| +40% | +$171K |
|
5090
MeiraGTx Holdings
MGTX
$1.25B
| $500K | ﹤0.01% |
59,352
-6,996
| -11% | -$61.7K |
|
5091
iShares Russell 2500 ETF
SMMD
$3.78B
| $498K | ﹤0.01% |
10,007
+4,571
| +84% | +$252K |
|
5092
Tonix Pharmaceuticals
TNXP
$218M
| $498K | ﹤0.01% |
47
+3
| +7% | +$73.6K |
|
|
IVC
5093
DELISTED
Invacare Corporation
IVC
| $498K | ﹤0.01% |
638,859
-364,533
| -36% | -$384K |
|
|
OPRA
5094
Opera Ltd
OPRA
$1.82B
| $497K | ﹤0.01% |
114,668
-10,696
| -9% | -$51.4K |
|
5095
Noodles & Co
NDLS
$107M
| $496K | ﹤0.01% |
13,207
+5,909
| +81% | +$235K |
|
5096
ProShares UltraShort Bloomberg Crude Oil
SCO
$594M
| $496K | ﹤0.01% |
4,093
-39,905
| -91% | -$4.04M |
|
5097
Superior Group of Companies
SGC
$208M
| $496K | ﹤0.01% |
55,922
+21,063
| +60% | +$303K |
|
|
PIM
5098
Franklin Master Intermediate Income Trust
PIM
$153M
| $493K | ﹤0.01% |
151,656
-56,046
| -27% | -$192K |
|
5099
FerroAtlántica
GSM
$820M
| $491K | ﹤0.01% |
93,153
-34,181
| -27% | -$212K |
|
5100
Northrim BanCorp
NRIM
$606M
| $491K | ﹤0.01% |
47,204
-74,056
| -61% | -$759K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.